Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
Closed Posted
- Opportunity number
- CDC-RFA-CK-26-0221
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Applications due
- Award size
- $250,000 to $1,250,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- 501(c)(3) Nonprofits
- Other
- Higher Education Inst. (Private)
- State Governments
- Unrestricted
- Independent School Districts
- Public or Indian Housing Auth.
- For Profit Organizations
- Higher Education Inst. (Public)
- Tribal Organizations (Not Federally Recognized)
- Small Businesses
- Tribal Governments (Federally Recognized)
- Non-501(c)(3) Nonprofits
- City/Township Governments
- County Governments
- Special District Governments
- Points of contact
-
- Jamal Choice qhi2@cdc.gov
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention is soliciting cooperative agreement applications to reduce the burden of parasitic infections in the United States through evidence-based prevention and control activities, with applications due July 17, 2026.
The opportunity is open to an unrestricted applicant pool: 501(c)(3) and non-501(c)(3) nonprofits, higher education institutions (public and private), state and local governments (county, city, township, special district), tribal governments (federally and non-federally recognized), small businesses, for-profit organizations, independent school districts, and public or Indian housing authorities.
The funding instrument is a cooperative agreement under CFDA 93.084 (Prevention of Disease, Disability, and Death by Infectious Diseases). Project periods run one to five years, with annual renewals within multi-year awards made via non-competitive process subject to fund availability.
The program targets two component areas: Component A focuses on Chagas disease activities, including epidemiologist positions to coordinate trainings, webinars and educational resource development, congenital Chagas disease screening program implementation, and capacity strengthening for diagnosis and management. Component C addresses other parasitic diseases of public health importance. Eligible activities include development and dissemination of U.S. clinical practice guidelines and specimen banking for evaluating diagnostic algorithm components as part of program evaluation.
Competitiveness is assessed on how well proposed activities align with the logic model for each component. Independent agencies in the same state may apply separately if activities are not duplicative.
Applications will be evaluated on scientific and technical merit through objective or peer review, availability of funds, and relevance to program priorities and CDC priorities, as specified in the individual NOFO. The detailed RFA (cdc-rfa-ck-26-0221_forPublication.pdf, posted June 17, 2026) and Q&A clarifications (posted June 25, 2026) provide scope determinations and competitiveness guidance.
Synopsis
Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
Files
| File | Type | Posted |
|---|---|---|
| Q&A's.docx | DOCX document | |
| cdc-rfa-ck-26-0221_forPublication.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity